Whistleblower Lawsuit Against California Lap-Band Clinic

California’s Dept. of Insurance launched an investigation into the business practices of surgery centers participating in the 1-800-GET-THIN campaign for Lap-Band gastric band surgery.  As death tolls were rising, and lawmakers were getting concerned about the business practices and the safety of consumers it was time that something had to be done.

Whistleblower Lawsuit Against Lap-Band Clinic

And now, in more news, a California Lap-Band clinic has just been named in a whistleblower lawsuit. Two former employees of a San Diego Lap-Band clinic are suing the clinic and the once ubiquitous 1-800-GET-THIN marketing campaign. The two allege that the device and the campaign put patients at risk. Jessica Meyle, a dietitian, and Amy Demonbreun, a surgical technologist, allege that several factors exposed patients at the San Diego Ambulatory Surgery Center to unsafe care, such as inappropriately sterilized equipment and a questionable business model in which quotas were required for patient referrals, said UT San Diego.

The women, according to court documents, complained to their employers, but to no avail. The case was filed last week in Los Angeles County Superior court. The San Diego Ambulatory Surgery Center denies the allegations, saying that the claims about unsterilized equipment are “a total fabrication,” said UT San Diego. The women contend that some patients who received procedures at the clinic’s San Diego location on December 30th and the Beverly Hills Surgery Center in January, could have been exposed to hepatitis C, according to court papers, said UT San Diego. The women also allege that they are not aware of any steps their employer or any other defendants took to contact potentially impacted patients, said UT San Diego. Both women resigned in 2012 and, an attorney for the women explained that, “They quit because they were being ordered to do things that were not legal,” according to UT San Diego.

The controversial Lap-Band is a silicone ring implanted around the stomach to curb an obese person’s appetite. The device, manufactured by Allergan Inc., is designed to promote rapid weight loss, but has been linked to a growing number of unexpected complications and side effects blamed on the device and the surgeons’ implanting the Lap-Band.

Other lawsuits have been filed against 1-800-GET-THIN, including one concerning ads created by or on behalf of Julian and Michael Omidi of Beverly Hills and referring patients to one of more than one dozen Omidi-owned surgery centers in Southern California. Both brothers are also named as defendants in this case; Julian Omidi’s medical license was revoked in 2009 by the California medical board and Michael just completed a three-year probation, also ordered by the board, said UT San Diego. Omidis’ attorney claims the brothers “have nothing to do” with the clinic and voluntarily resigned from their jobs.

Allergan Inc. is currently facing a federal subpoena concerning the surgical device.  The subpoena was sourced to the Department of Health and Human Services and concerns a recent Congressional call for a hearing to discuss the safety of Lap-Band after a report in Archives of Surgery associated the devices with an extremely high failure rate and a link to “long term complications.” That study found that about half of all Lap-Band recipients were contemplating a removal of the devices after just six years and nearly 40% of patients were bound to suffer long term pain and injuries rooted to the devices.

Despite growing evidence that Lap-Band could be defective and dangerous by design and that a vast number of surgeons have not been well-versed in proper procedures for implanting them, the FDA approved the surgery for people with less severe cases of obesity, potentially putting thousands more people at risk for similar injuries. The Lap-Band design has been linked to erosion of the band through the stomach wall, stretching the esophagus and stomach pouch, stomach pain, gastroesophageal reflux disease, difficulty swallowing, nausea, and vomiting.



,

No comments yet.

Leave a Reply

GET HELP NOW!
  • This field is for validation purposes and should be left unchanged.
Latest Drug Injury News

Underground Railway Dust May Pose Health Risk

Travelling or working on an underground railway for sustained period of time could have health implications due to concentrations of metal-rich microscopic dust particles.

New Study Helps Understand Why Health Care Costs On The Rise

Although many believe is it medical malpractice suites that are causing the increase in the health care costs, it is actually the fear of them that is partly to blame. Doctors are ordering unnecessary tests and procedures for fear of a patient filing a claim down the road

FDA Issues New Warnings Concerning Tolvaptan

The FDA has issued a drug safety communication concerning Tolvaptan, a selective vasopression V2-receptor antagonist used in heart failure patients to treat clinically significant hypervolemic and euvolemic hyponatremia.

New Antiepileptic Drug Causes Blue Discoloration And Vision Trouble

An antiepileptic drug to hit the market has been known to cause vision troubles and skin discoloration. Almost all patients experienced gray/blue skin discoloration who had been taking the pill for two years. More information is needed to better understand the occurrences.

Medical Mattresses Pose Risk Of Infection And Contamination

The FDA warns that medical mattresses may not be as clean as once perceived. Routine checks on mattresses are advised as any rips, tears, or excessive wear alter the efficacy. The medical mattresses as well as the covers have an expected life depending on the manufacturer, which should not go unnoticed.

Latest Medical Device Injury News

Women 30% More Likely To Need Repeat Hip Implant Surgery

Doctors traditionally believed the larger the size of the implant, the more protective it was against failure, according to Sedrakyan. However, he said his study found regardless of size, women had a higher rate of revision occurrence, so some other factor besides the actual implants may be leading to this effect.

Transvaginal Mesh Lawsuits – Who Is At Fault?

For some women a pelvic transvaginal mesh product has been a god sent.  To be able to resume a full active life, without the worry of a leaky bladder, is a true miracle for some women.  And, this only became possible with the help of pelvic mesh. The mesh is most commonly used after pelvic [...]

Metal-on-Metal Hip Implants Cause Soft Tissue Damage Says FDA

Hip joint deterioration can lead to pain, stiffness or difficulty walking. When these symptoms do not respond to conservative treatment, such as physical therapy, patients may be advised to undergo total hip replacement or hip resurfacing. As part of this treatment, they may receive a “metal-on-metal” hip implant in which the “ball and socket” of [...]

Ethicon Recalls Surgical Stapler

The FDA has announced a voluntary global recall of more than 157,000 Ethicon surgical staplers, due to problems with incomplete firing strokes that may cause faulty staple formation, potentially resulting in painful and severe internal complications for the patient. An Ethicon surgical stapler recall was first announced in August, after reports surfaced where surgeons experienced [...]

Another Device Maker Investigated By DOJ

Earlier this month, cardiovascular device maker Abiomed announced that the US Attorney’s Office was investigating the company’s marketing and labeling of the Impella 2.5 circulatory support device. According to Forbes, the announcement confirmed rumors that had been circulating for at least two weeks, though in the press release the company said it had just been [...]